DAVITA INC. Interest Costs Capitalized
DAVITA INC. (DVA) reported Interest Costs Capitalized of $7.98 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InterestCostsCapitalized · last filed 2025-02-13
- DAVITA INC. interest costs capitalized for fiscal 2024 was $7.98M, a 13.07% decline from fiscal 2023.
- DAVITA INC. interest costs capitalized for fiscal 2023 was $9.18M, a 27.60% decline from fiscal 2022.
- DAVITA INC. interest costs capitalized for fiscal 2022 was $12.68M, a 17.01% decline from fiscal 2021.
- DAVITA INC. interest costs capitalized for fiscal 2021 was $15.28M, a 14.87% decline from fiscal 2020.
| Period end | Interest Costs Capitalized 12 month |
|---|---|
| 2024-12-31 | $7.98M 10-K · filed 2025-02-13 |
| 2023-12-31 | $9.18M 10-K · filed 2025-02-13 |
| 2022-12-31 | $12.68M 10-K · filed 2025-02-13 |
| 2021-12-31 | $15.28M 10-K · filed 2024-02-14 |
| 2020-12-31 | $17.94M 10-K · filed 2023-02-22 |
| 2019-12-31 | $27.32M 10-K · filed 2022-02-11 |
| 2018-12-31 | $25.98M 10-K · filed 2021-02-12 |
| 2017-12-31 | $19.18M 10-K · filed 2020-02-21 |
| 2016-12-31 | $12.99M 10-K · filed 2019-02-22 |
| 2015-12-31 | $9.72M 10-K · filed 2018-02-23 |
| 2014-12-31 | $7.89M 10-K · filed 2017-02-24 |
| 2013-12-31 | $6.41M 10-K · filed 2016-02-26 |
| 2012-12-31 | $8.13M 10-K · filed 2015-02-26 |
| 2011-12-31 | $4.89M 10-K · filed 2014-02-21 |
| 2010-12-31 | $2.62M 10-K · filed 2013-03-01 |
| 2009-12-31 | $3.63M 8-K · filed 2012-07-06 |
| 2008-12-31 | $4.19M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |